Journal article icon

Journal article

Potential coverage of the 4CMenB vaccine against invasive serogroup B Neisseria meningitidis isolated from 2009 to 2013 in the Republic of Ireland

Abstract:

Neisseria meningitidis is a common cause of bacterial meningitis in children and young adults worldwide. The 4CMenB vaccine (Bexsero), developed to combat meningococcal serogroup B (MenB) disease, contains subcapsular antigens that may induce immunity against strains of N. meningitidis, regardless of serogroup. Owing to differential levels of expression and peptide diversity in vaccine antigens across meningococcal strains, the meningococcal antigen typing system (MATS) was developed to estim...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1128/mSphere.00196-18

Authors


Expand authors...
GlaxoSmithKline Biologicals SA More from this funder
Publisher:
American Society for Microbiology Publisher's website
Journal:
Clinical and Vaccine Immunology Journal website
Volume:
3
Issue:
4
Pages:
e00196-18
Publication date:
2018-08-22
Acceptance date:
2018-07-23
DOI:
EISSN:
1556-679X
ISSN:
1556-6811
Keywords:
Pubs id:
pubs:890975
UUID:
uuid:5e36bfb1-8ba8-488a-b3ff-2e61cf3d5276
Local pid:
pubs:890975
Deposit date:
2018-07-24

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP